The present work aimed at developing pharmaceutical dosage forms based on the dry bark extract of Libidibia ferrea for the treatment of diabetes mellitus. The physicochemical characterization of the plant raw material, extractive solution and dry extract obtained by freeze drying were carried out. Effervescent granules, oral solution and tablets from the dry extract were developed and subjected to the recommended quality control tests. All materials presented standardized values after physical-chemical characterization. The presence of several secondary compounds was confirmed, and the content of the tannins was determined. The extract did not present acute toxicity in the in vivo experiment and provided an increase in glucose uptake in the in vitro study. The developed formulations complied with previously established values for quality control. The results show the safety and efficacy of the developed products, may being promising options in the treatment of diabetes mellitus.